Literature DB >> 22821985

Drosophila dosage compensation involves enhanced Pol II recruitment to male X-linked promoters.

Thomas Conrad1, Florence M G Cavalli, Juan M Vaquerizas, Nicholas M Luscombe, Asifa Akhtar.   

Abstract

Through hyperacetylation of histone H4 lysine 16 (H4K16), the male-specific lethal (MSL) complex in Drosophila approximately doubles transcription from the single male X chromosome in order to match X-linked expression in females and expression from diploid autosomes. By obtaining accurate measurements of RNA polymerase II (Pol II) occupancies and short promoter-proximal RNA production, we detected a consistent, genome-scale increase in Pol II activity at the promoters of male X-linked genes. Moreover, we found that enhanced Pol II recruitment to male X-linked promoters is largely dependent on the MSL complex. These observations provide insights into how global modulation of chromatin structure by histone acetylation contributes to the precise control of Pol II function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821985     DOI: 10.1126/science.1221428

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  38 in total

Review 1.  Dosage Compensation in Drosophila-a Model for the Coordinate Regulation of Transcription.

Authors:  Mitzi I Kuroda; Andres Hilfiker; John C Lucchesi
Journal:  Genetics       Date:  2016-10       Impact factor: 4.562

2.  Male-specific lethal complex in Drosophila counteracts histone acetylation and does not mediate dosage compensation.

Authors:  Lin Sun; Harvey R Fernandez; Ryan C Donohue; Jilong Li; Jianlin Cheng; James A Birchler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 3.  Transcriptional control of a whole chromosome: emerging models for dosage compensation.

Authors:  Francesco Ferrari; Artyom A Alekseyenko; Peter J Park; Mitzi I Kuroda
Journal:  Nat Struct Mol Biol       Date:  2014-02-05       Impact factor: 15.369

Review 4.  Facts and artifacts in studies of gene expression in aneuploids and sex chromosomes.

Authors:  James A Birchler
Journal:  Chromosoma       Date:  2014-07-29       Impact factor: 4.316

5.  Functional interplay between MSL1 and CDK7 controls RNA polymerase II Ser5 phosphorylation.

Authors:  Sarantis Chlamydas; Herbert Holz; Maria Samata; Tomasz Chelmicki; Plamen Georgiev; Vicent Pelechano; Friederike Dündar; Pouria Dasmeh; Gerhard Mittler; Filipe Tavares Cadete; Fidel Ramírez; Thomas Conrad; Wu Wei; Sunil Raja; Thomas Manke; Nicholas M Luscombe; Lars M Steinmetz; Asifa Akhtar
Journal:  Nat Struct Mol Biol       Date:  2016-05-16       Impact factor: 15.369

Review 6.  Dosage compensation of the sex chromosomes.

Authors:  Christine M Disteche
Journal:  Annu Rev Genet       Date:  2012-09-04       Impact factor: 16.830

7.  Condensin controls recruitment of RNA polymerase II to achieve nematode X-chromosome dosage compensation.

Authors:  William S Kruesi; Leighton J Core; Colin T Waters; John T Lis; Barbara J Meyer
Journal:  Elife       Date:  2013-06-18       Impact factor: 8.140

8.  Mammalian X upregulation is associated with enhanced transcription initiation, RNA half-life, and MOF-mediated H4K16 acetylation.

Authors:  Xinxian Deng; Joel B Berletch; Wenxiu Ma; Di Kim Nguyen; Joseph B Hiatt; William S Noble; Jay Shendure; Christine M Disteche
Journal:  Dev Cell       Date:  2013-03-21       Impact factor: 12.270

9.  Comment on "Drosophila dosage compensation involves enhanced Pol II recruitment to male X-linked promoters".

Authors:  F Ferrari; Y L Jung; P V Kharchenko; A Plachetka; A A Alekseyenko; M I Kuroda; P J Park
Journal:  Science       Date:  2013-04-19       Impact factor: 47.728

10.  Tandem stem-loops in roX RNAs act together to mediate X chromosome dosage compensation in Drosophila.

Authors:  Ibrahim Avsar Ilik; Jeffrey J Quinn; Plamen Georgiev; Filipe Tavares-Cadete; Daniel Maticzka; Sarah Toscano; Yue Wan; Robert C Spitale; Nicholas Luscombe; Rolf Backofen; Howard Y Chang; Asifa Akhtar
Journal:  Mol Cell       Date:  2013-07-25       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.